Zusammenfassung
Organerkrankungen im Endstadium sowie der Verlust gesunder, funktionsfähiger Organe und Organ strukturen konfrontieren Medizin und Gesellschaft mit therapeutisch wie sozioökonomisch immensen Problemen. Durch Identifizierung neuer und Verbesserung bestehender Therapieoptionen und hier insbesondere auch der Transplantation von Geweben und Organen konnten im Laufe der letzten Jahre vielfach deutliche therapeutische Fortschritte erzielt und dabei die Prognose einer Reihe von Erkrankungen deutlich verbessert werden. Beide Therapieansätze — rekonstruierend wie substituierend — sind jedoch auch heute noch mit Nachteilen behaftet, die ihre Anwendbarkeit limitieren. Beispiele hierfür sind insbesondere:
-
eine zunehmend große Diskrepanz zwischen Verfügbarkeit und Bedarf an Organen,
-
Entwicklung sekundärer Gesundheitsrisiken wie z. B. Ausbildung von Neoplasien durch notwendige und unabdingbare lebenslange immun suppressive Therapien nach Organtransplantation,
-
Mangel an Spendergeweben wie z. B. arterielle und venöse Blutgefäße allogenen, aber auch autologen Ursprungs,
-
gesteigertes Risiko für Infektionen und thromboembolische Komplikationen nach Implantation mechanischer und alloplastischer Prothesen,
-
gesteigertes Risiko für das Auftreten von Blutungskomplikationen unter antikoagulativer Therapie, die aufgrund einer gesteigerten intrinsischen Thrombogenität alloplastischer Implantate zumeist lebenslang aufrechterhalten werden muss.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akins RE, Byce RA, Madonna ML et al.(1999) Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng 5: 103–118
Asahara T, Murohara T, Sullivan A et al.(1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964–967
Assmus B, Schainger V, Teupe C et al.(2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009–3017
AVID Clinical Trial Center (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resucitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337: 1576–1583
Badorff C, Brandes RP, Popp R et al.(2003) Transdifferentiaton of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024–1032
Barratt-Boyes BG (1965) A method for preparing and inserting a homograft aortic valve. B J Surg 52: 847–856
Bechtel JFM, Schmidtke C, Mueller-Steinhardt M et al.(2003) Evaluation of a decellularized homograft valve for reconstruction of the right ventricular outflow tract in the Ross-procedure. Second Biennal Meeting of the Society for Heart Valve Disease 2003. 28.06.–01.07.2003. Palais des Congres — Porte Maillot, Paris, 347
Beltrami CA, Finato N, Rocco M et al.(1994) Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89: 101–163
Bishop SP, Anderson PG, Tucker DC (1990) Morphological development of the rat heart growing in oculo in the abscence of hemodynamic work load. Circ Res 66: 84–102
Campbell JH, Efendy JL, Campbell GR (1999) Novel vascular graft grown within recipient’s own peritoneal cavity. Circ Res 85: 1173–1178
Carrel A (1902) La technique opératoire des anastomoses vascularies et le transplantation des viscères. Lyon Med 89
Carrier RL, Papadaki M, Rupnick M et al, (1999) Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64: 580–589
Carrier RL, Rupnick M, Langer R et al.(2002) Effects of oxygen on engineered cardiac muscle. Biotechol Bioeng 78: 617–625
Cebotari S, Lichtenberg A, Tudorache I et al.(2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114 (1 Suppl): I132–I137
Cebotari S, Mertsching H, Kallenbach K et al.(2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106 (12 Suppl 1): 163–168
Chambard M, Gabrion J, Mauchamp J (1981) Influence of collagen gel on the orientation of epithelial cell polarity: follicle formation from isolated thyroid cells and from preformed monolayers. J Cell Biol 91: 157–166
Condorelli G, Borelli UV, DeAngelis L et al.(2001) Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci USA 98: 10733–10738
Crawford ES, De Bakey ME, Morris GC Jr et al.(1960) Evaluation of late failures after reconstructive operations for occlusive lesions of the aorta and iliac, femoral, and popliteal arteries. Surgery 47: 79–104
Dardik H (1995) The second decade of experience with the umbilical vein graft for lower-limb revascularization. Cardiovasc Surg 3: 265–269
Dardik H, Miller N, Dardik A et al.(1988) A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vase Surg 7: 336–346
Dardik I, Darkik H (1973) Vascular heterograft: human umbilical cord vein as an aortic substitute in baboon. A preliminary report. J Med Primatol 2: 296–301
DeBakey ME, Cooley DA, Crawford ES (1958a) Surgical consideration of occlusive disease of the abdominal aorta and iliac and femoral arteries: Analysis of 803 cases. Ann Surg 148: 306–324
DeBakey ME, Cooley DA, Crawford ES (1958b) Clinical application of a new flexible knitted Dacron arterial substitute. Arch Surg 77: 213–224
DeLaurentis DA, Friedmann P (1972) Sequential femoropopliteal bypasses: another approach to the inadequate saphenous vein problem. Surgery 71: 400–404
Deutsch M, Meinhart J, Fischlein T et al.(1999) Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126: 847–855
Dohmen PM, Lembcke A, Hotz H et al.(2002a) Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74: 1438–1442
Dohmen PM, Ozaki S, Verbeken E et al.(2002b) Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc Thoracic Ann 10: 25–30
Dubost C, Allary M, Oeconomos N (1952) Resection of an aneurysm of the abdominal aorta: Restablishment of the continuity by a preserved human arterial graft, with result after five months. Arch Surg 64: 405–408
Echt DS, Liebson PR, Mitchell LB et al.(1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324: 781–788
Edelman ER (1999) Vascular tissue engineering: designer arteries. Circ Res 85: 1115–1117
Edwards WS, Tapp JS (1955) Chemically treated nylon tubes as arterial grafts. Surgery 38: 61–70
Eschenhagen T, Fink C, Remmers U et al.(1997) Three-dimensional reconstruction of embryonic cardiomyocytes on a collagen matrix: a new heart muscle model system. Faseb J 11: 683–694
Eschenhagen T, Zimmermann WH (2005) Engineering myocardial tissue. Circ Res 97: 1220–1231
Fast VG, Darrow BJ, Saffitz JE et al.(1996) Anisotropic activation spread in heart cell monolayers assessed by high-resolution optical mapping. Role of tissue discontinuities. Circ Res 105: 115–127
Feld Y, Melamed-Frank M, Kehat I et al.(2002) Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel stragety to manipulate excitability. Circulation 105: 522–529
Ferber D (1999) Lab-grown organs begin to take shape. Science 284: 422–423, 425
Fink C, Ergun S, Kralisch D et al.(2000) Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Faseb J 14: 669–679
Flinn WR, McDaniel MD, Yao JST, Fahey VA, Green D (1984) Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction. J Vasc Surg 1: 888–895
Folkman J (1971) Tumor angiogenesis: the rapeutic implications. N Engl J Med 285: 1182–1186
Fuster V, Badimon L, Badimon JJ et al.(1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 242–250
Gaudesius G, Miragoli M, Thomas SP et al.(2003) Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93: 421–428
Gepstein L (2003) Derivation and potential applications of human embryonic stem cells. Circ Res 91: 866–876
Gepstein L, Feld Y, Yankelson L (2004) Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am J Physiol Heart Circ Physiol 286: 815–822
Ginalska G, Kowalczuk D, Osinska M (2005) A chemical method of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int J Pharm 288: 131–140
Ginalska G, Osinska M, Uryniak A et al.(2005) Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur J Vasc Endovasc Surg 29: 419–424
Goldstein S, Clarke DR, Walsh SP et al.(2000) Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 70: 1962–1969
Goyanes J (1906) Nuevos trabajos de cirurgia vascular. Siglo Med 53: 446–561
Gross RE, Bill AH (1948) Preliminary observations on the use of the human arterial grafts in the treatment of certain cardiovascular defects. N Engl J Med 239: 578–591
Gross RE, Bill AH, Preice EC (1949) Methods for preservation and transplantation of arterial grafts: Observations on arterial grafts in dogs; Report on transplantation of preserved arterial grafts in nine human cases. Surg Gynecol Obstet 88: 68–71
Guido S, Tranquillo RT (1993) A methodology for the systematic and quantitative study of cell contact guidance in oriented collagen gels. Correlation of fibroblast orientation and gel birefringence. J Cell Sci 105: 317–331
Gulbins H, Goldemund A, Uhlig A et al.(2003) Implantation of an autologously endothelialized homo graft. J Thorac Cardiovasc Surg 126: 890–891
Hajjar RJ, del Monte F, Matsui T et al.(2000) Prospects for gene therapy for heart failure. Circ Res 86: 616–621
Hall HG, Farson DA, Bissell MJ (1982) Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci USA 79: 4672–4676
Harrison JH (1958) Synthetic materia Is as vascular prostheses: 2. A comparative study of Nylon, Dacron, Orion, IvaIon sponge and Teflon in large vessels with tensile strength studies. Am J Surg 95: 16–24
Hill JM, Syed MA, Arai AE et al.(2005) Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 46: 1643–1648
Hoerstrup SP, Sodian R, Sperling JS et al.(2000) New pulsatile bio reactor for in vitro formation of tissue engineered heart valves. Tissue Eng 6: 75–79
Hubbell JA, Massia SP, Desai NP et al.(1991) Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (NY) 9: 568–572
Hufnagel CA (1947) Preserved homologous arterial transplants. Bull Am Coll Surg 32: 231
Huynh T, Abraham G, Murray J et al.(1999) Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17: 1083–1086
Isner JM (2002) Myocardial gene therapy. Nature 415: 234–239
Isomatsu Y, Shin’oka T, Matsumura G et al.(2003) Extracardiac total cavo pulmo nary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 126: 1958–1962
Kang HJ, Kim HS, Zhang SY et al.(2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751–756
Kehat I, Amit M, Gepstein A et al.(2001a) Functional integration of human embryonicstem cell derived cardiomyocytes with preexisting cardiac tissue: Implication for myocardial repair. Circulation 104 (Suppl II): 618
Kehat I, Kenyagin-Karsenti D, Snir M et al.(2001b) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407–414
Kofidis T, Akhyari P, Boublik J et al.(2002) In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124: 63–69
Kofidis T, de Bruin JL, Hoyt G et al.(2005) Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 24: 737–744
Kofidis T, Lenz A, Boublik J et al.(2003) Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24: 5009–5014
Kolodney MS, Elson EL (1993) Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 268: 23850–23855
Korecky B, Hai CM, Rakusan K (1982) Functional capillary density in normal and transplanted rat hearts. Can J Physiol Pharmacol 60: 23–32
Kunlin J (1949) Le traitement de L’ischémie oblitérante par la greffe veineuse longue. Arch Mal de Couer 42: 371–372
Kuo MD, Waugh JM, Yuksel E et al.(1998) 1998 ARRS President’s Award. The potential of in vivo vascular tissue engineering for the treatment of vascular thrombosis: a preliminary report. American Roentgen Ray Society. AJR Am J Roentgenol 171: 553–558
Lachapelle K, Graham AM, Symes JF (1994) Antibacterial activity, antibiotic retention, and infection resistance of a rifam pin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 19: 675–682
Langer R, Vacanti JP (1993) Tissue engineering. Science 260: 910–926
Laube HR, Duwe J, Rutsch W et al.(2000) Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery by pass grafts. J Thoracic Cardiovasc Surg 120: 134–141
Leor J, Aboulafia-Etzion S, Dar A et al.(2000) Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102: III56–III61.
L’Heureux N, Dussere N, Konig G et al.(2006) Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12: 361–365
L’Heureux N, Paquet S, Labbe R et al.(1998) A completely biological tissue-engineered human blood vessel. Faseb J 12: 47–56
Li RK, Jia ZQ, Weisel RD et al.(1999) Survival and function of bioengineered cardiac grafts. Circulation 100: 1163–1169
Linton RR, Darling RC (1962) Autogenous saphenous vein bypass grafts in femorapopliteal obliterative arterial disease. Surgery 51: 62–73
Makino S, Fukuda K, Miyoshi A et al.(1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697–705
Martin Y, Vermette P (2005) Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26: 7481–7503
McDonald TF, Sachs HG, De Haan RL (1972) Development of sensitivity to tetrodotoxin in beating chick embryo hearts, single cells, and aggregates. Science 176: 1248–1250
Menasche P, Hagege AA, Scorsin M et al.(2001) Myoblast transplantation for heart failure. Lancet 357: 279–280
Menasche P, Hagege AA, Vilquin JT et al.(2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078–1083
Miller JH, Foreman RK, Ferguson L et al.(1984) Interposition vein cuff for anastomosis of prosthesis to small artery. Aust N Z J Surg 54: 283–285
Miwa H, Matsuda T (1994) An integrated approach to the design and engineering of hybrid arterial prostheses. J Vasc Surg 19: 658–667
Moscona AA (1959) Tissues from dissociated cells. Contrib Embryol Carnegie Inst 200: 132–134
Moss AJ, Zarebe W, Hall WJ et al.(2002a) Multicenter Automatic Defibrillator Implantation Trial II Investigators. N Engl J Med 346: 877–883
Moss AJ, Zarebe W, Hall WJ et al.(2002b) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877–883
Muller-Ehmsen J, Peterson KL, Kedes L et al.(2002) Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardio-myocytes after myocardial infarction and effect on cardiac function. Circulation 105: 1720–1726
Mummery C, van Oostwaard D, Doevendans P et al.(2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107: 2733–2740
Murphy JB (1897) Resection of arteries and veins injured in continuity — end-to-end suture: Experimental results and clinical research. Med Res 31: 73–88
Murugesan G, Ruegsegger MA, Kligman F et al.(2002) Integrin-dependent interaction of human vascular endothelial cells on biomimetic peptide surfactant polymers. Cell Commun Adhes 9: 59–73
Nerem RM (1992) Tissue engineering in the USA. Med Biol Eng Comput 30: CE8–CE12
Niklason LE, Gao J, Abbott WM et al.(1999) Functional arteries grown in vitro. Science 284: 489–493
O’Brien MF, Goldstein S, Walsh S et al.(1999) The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization: first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11: 194–200
Orlic D, Kajstura J, Chimenti S et al.(2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705
Outdot J (1951) La greffe vasculaire dans les thromboses du Carrefour aortique. Presse Med 59: 234
Outdot J, Beaconsfield P (1953) Thromboses of the aortic bifurcation treated by resection and homograft replacement. Arch Surg 66: 365–374
Ozawa T, Mickle DA, Weisel RD et al.(2004) Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant 13: 169–177
Pavcnik D, Uchida BT, Timmermans HA et al.(2002) Percutaneous bio-prosthetic venous valve: A long-term study in sheep. J Vase Surg 35: 598–602
Pittenger MF, Mackay AM, Becks SC et al.(1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147
Radisic M, Deen W, Langer R et al.(2005) Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288: H1278–H1289
Radisic M, Park H, Shing H et al.(2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 101: 18129–18134
Rahlf G, Urban P, Bohle RM (1986) Morphology of healing in vascular prostheses. Thorac Cardiovasc Surg 34: 43–48
Rakusan K, Flanagan MF, Geva T et al.(1992) Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overlaod hypertrophy. Circulation 86: 38–46
Ratajska A, Ciszek B, Sowinska A (2003) Embryonic development of coronary vasculature in rats: corrosion casting studies. Anat Rec Discov Mol Cell Evol Biol 270: 109–116
Reinlib L, Field L (2000) Cell transplantation as future therapy for cardiovascular disease? A workshop of the National Heart, Lung, and Blood Institute. Circulation 101: E182–E187
Rook MB, van Ginneken AC, de Jonge B et al.(1992) Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. Am J Physiol Cell Physiol 263: C959–C977
Rosenberg N (1976) The bovine arterial graft and its several applications. Surg Gynecol Obstet 142: 104–108
Rosenberg NG, Henderson J (1956) The use of segmental arterial implants prepared by enzymatic modification of heterologous blood vessels. Surg Forum 6: 242
Ross D (1967) Homograft replacement of the aortic valve. B J Surg 54: 842–843
Sagnella S, Anderson E, Sanabria N et al.(2005) Human endothelial cell interaction with biomimetic surfactant polymers containing peptide ligands from the heparin binding domain of fibronectin. Tissue Eng 11: 226–236
Sagnella S, Kligman F, Marchant RE et al.(2003) Biometrie surfactant polymers designed for shear-stable endothelialization on biomaterials. J Biomed Mater Res A 67: 689–701
Sauvage LR, Berger KE, Mansfield PB et al.(1974) Future directions in the development of arterial prostheses for small and medium caliber arteries. Surg Clin North Am 54: 213–228
Schaner PJ, Martin ND, Tulenko TN et al.(2004) Decellularized vein as a potential scaffold for vascular tissue engineering. J Vase Surg 40: 146–153
Scheinman MM (1995) NASPE survey on catheter ablation. Pacing Clin Electrophysiol 18: 1474–1478
Schmidt CE, Baier JM (2000) Acellular vascular tissues: natural bio materia Is for tissue repair and tissue engineering. Biomaterials 21: 2215–2231
Schram G, Pourrier M, Melnyk P et al.(2002) Differential distribution of cardiacion channel expression as a basis for regional specialization in electrical function. Circ Res 90: 939–950
Seifalian AM, Tiwari A, Hamilton G et al.(2002) Improving the clinical patency of prosthetic vascular and coronary bypass g rafts: the role of seeding and tissue engineering. Artif Organs 26: 307–320
Shimizu T, Sekine H, Isoi Y et al.(2006) Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng 12: 499–507
Shimizu T, Yamato M, Isoi Y et al.(2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90: e40
Shinoka T, Breuer CK, Tanel RE (2002) Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. Artif Organs 26: 402–406
Shinoka T, Breuer CK, tanel RE et al.(1995) Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 60: S513–S516
Shinoka T, Shum-Tim D, Ma PX et al.(1998) Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115: 536–545; discussion: 545–546
Shumaker HB, King H (1954) The use of pliable tubes as aortic substitutes in man, Surg Gynecol Obstet 94: 287–294
Shum-Tim D, Stock U, Hrkach J et al.(1999) Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68: 2298–2304
Siegman FA (1979) Use of the venous cuff for graft anastomosis. Surg Gynecol Obstet 148: 930
Simon P, Kasimir MT, Seebacher G et al.(2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23: 1002–1006; discussion: 1006
Simpson DG, Terracio L, Terracio M et al.(1994) Modulation of cardiac myocyte phenotype in vitro by the compositon and orientation of the extracellular matrix. J Cell Physiol 161: 89–105
Skalak R, Fox C (1988) Tissue engineering. In: Skalak R, Fox C (eds) Workshop on tissue engineering, 26.–29.02.1988. Granlibakken, Lake Tahoe; Liss, New York
Sodian R, Hoerstrup SP, Sperling JS et al.(2000) Early In vivo experience with tissue-engineered trileaflet heart valves. Circulation 102: III22–III29
Souren JE, Schneijdenberg C, Verkleij AJ et al.(1992) Factors controlling the rhythmic contraction of collagen gels by neonatal heart cells. In Vitro Cell Dev Biol 28a: 199–204
Sparks CH (1973) Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ. Ann Surg 177: 293–300
Steinhoff G, Stock U, Karim N et al.(2000) Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 102: III50–III55
Stock UA, Nagashima M, KhaliI PN et al.(2000) Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 119: 732–740
Sys SU, Pellegrino D, Mazza R et al.(1997) Endocardial endothelium in the avascular heart of the frog: morphology and role of nitric oxide. J Exp Biol 200: 3109–3118
Szilagyi DE, France LC, Smith RF (1958) Clinical use of an elastic Dacron prosthesis. Arch Surg 77: 538–551
Szilagyi DE, McDonald RT, Smith RF (1957) Biologic fate of human arterial homografts. Arch Surg 75: 506–529
Taylor DA, Atkins BZ, Hungspreugs P et al.(1998) Regenerating functional myocardium; improved performance after skeletal myoblast transplantation. Nat Med 4: 929–933
Taylor RS, Loh A, McFarland RJ et al.(1992) Improved technique for polytetrafluoroethylene bypass grafting; long-term results using anastomotic vein patches. Br J Surg 79: 348–354
Teebken OE, Haverich A (2002) Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 23: 475–485
Teebken OE, Wilhelmi M, Haverich A (2005) Tissue Engineering für Herzklappen und Gefäße. Der Chirurg 5: 453–466
Teebken OE, Bader A, Steinhoff G et al.(2000) Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 19: 381–286
Terracio L, Miller B, Borg TK (1988) Effects of cyclic mechanical stimulation of the cellular components of the heart: in vitro. In Vitro Cell Dev Biol 24: 53–58
Torbert J, Ronziere MC (1984) Magnetic alignment of collagen during self-assembly. Biochem J 219: 1057–1059
Tranquillo RT, Girton TS, Bromberek BA et al.(1996) Magnetically orientated tissue-equivalent tubes: application to a circumferentially orientated media-equivalent. Biomaterials 17: 349–357
Tucker OP, Syburra T, Augstburger M et al.(2002) Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Small intestine without mucosa as a growing vascular conduit: a porcine experimental study. J Thorac Cardiovasc Surg 124: 1165–1175
Tyrrell MR, Wolfe JH (1991) New prosthetic venous collar anastomotic technique: combining the best of other procedures. Br J Surg 78: 1016–1017
Vacanti JP (1988) Beyond transplantation. Third annual Samuel Jason Mixter lecture. Arch Surg 123: 545–549
Vacanti JP, Langer R (1999) Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354 (Suppl 1): SI32–SI34
Vandenburgh HH, Karlisch P, Farr L (1988) Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell Dev Biol 24: 166–174
Vandenburgh HH, Swasdison S, Karlisch P (1991) Computer-aided mechanogenesis of skeletal muscle organs from single cells in vitro. Faseb J 5: 2860–2867
Vara DS, Salacinski HJ, Kannan RY et al.(2005) Cardiovascular tissue engineering: state of t he art. Pathol Biol (Paris) 53: 599–612
Vogt PR, Stallmach T, Niederhauser U et al.(1999) Explanted cryopre-served allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 15: 639–644; discussion: 644–645
Voorhees AB, Jaretzki A, Blakemore AH (1952) The use of tube constructed from Vinyon “n” cloth in bridging arterial defects. Ann Surg 135: 332–336
Weinberg CB, Bell E (1986) A blood vessel model constructed from collagen and cultured vascular cells. Science 231: 397–400
Wilhelmi MH, Mertsching H, Wilhelmi M et al.(2003a) Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis 12: 520–526
Wilhelmi MH, Rebe P, Leyh R et al.(2003b) Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep. Int J Art if Organs 26: 411–420
Williams SK (1995) Endothelial cell transplantation. Cell Transplant 4: 401–410
Wilson GJ, Courtman DW, Klement P et al.(1995) Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 60: S353–S358
Wollert KC, Meyer GP, Lotz J et al, (2004) Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141–148
Yoon YS, Park JS, Tkebuchava T et al.(2004) Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109: 3154–3157
Zehr KJ, Yagubyan M, Connolly HM et al.(2005) Aortic root replacement with a novel decellularized cryopreserved aortic homograft: ostoperative immunoreactivity and early results. J Thorac Cardiovasc Surg 130: 1010–1015
Zimmermann WH, Eschenhagen T (2003) Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8: 259–269
Zimmermann WH, Fink C, Kralisch D et al.(2000) Three-dimensional engineerined heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68: 106–114
Zimmermann WH, Schneiderbanger K, Schubert P et al.(2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223–230
Zuk PA, Zhu M, Mizuno H et al.(2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211–228
Zund G et al.(1998) Tissue engineering: a new approach in cardiovascular surgery: Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh. Eur J Cardiothorac Surg 13: 160–164
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haverich, A., Wilhelmi, M. (2010). Kardiovaskuläres “tissue engineering”. In: Herzchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79713-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-79713-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79712-8
Online ISBN: 978-3-540-79713-5
eBook Packages: Medicine (German Language)